During the past decade, DeNova Research conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 18 clinical trials were completed, i.e. on average, 62.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 15 clinical trials were completed. i.e. 93.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DeNova Research" #1 sponsor was "DeNova Research" with 17 trials, followed by "Allergan" with 5 trials sponsored, "Concert Pharmaceuticals" with 3 trials sponsored, "Ulthera, Inc" with 3 trials sponsored and "Kythera Biopharmaceuticals" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DeNova Research" #1 collaborator was "Galderma R&D" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Mentor Worldwide, LLC" with 1 trials as a collaborator and "Merz Aesthetics Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "DeNova Research" are "Skin Laxity" (4 trials), "Alopecia Areata" (3 trials), "Acne Vulgaris" (2 trials), "Submental Fat" (2 trials) and "Alopecia" (1 trials). Many other conditions were trialed in "DeNova Research" in a lesser frequency.

Most popular intervention types in "DeNova Research" are "Drug" (20 trials), "Device" (17 trials), "Other" (6 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ulthera System Treatment" (3 trials), "Bacteriostatic saline" (2 trials), "CTP-543" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "DeNova Research" are 37 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "DeNova Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in DeNova Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in DeNova Research, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 20 trials that are defined as “Not Applicable".